TRIALINGO is a tech-based service connecting non-native English-speaking cancer patients with clinical trial sponsors. Their mission is to democratize scientific breakthroughs and streamline drug development. Recruitment issues often impede progress, but TRIALINGO allows pharmaceutical companies to reach a diverse and motivated patient pool, accelerating the introduction of new, personalized medicines to market.